| Field | Specification |
|---|---|
| Target | |
| Alternative names | Nuclear egress protein 1; NEC1 |
| Gene ID | |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Conjugate | |
| Purification | |
| Cellular localization | |
| Concentration | |
| Form | Liquid |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody recognizes nuclear egress protein 1 (gene NEC1) in epstein-barr virus samples.
In Epstein-Barr virus, nuclear egress protein 1 (NEC1, encoded by BFLF2) works with NEC2 to move newly built capsids out of the host nucleus. The pair forms a complex at the inner nuclear membrane that makes capsids bud into the perinuclear space and then fuse with the outer membrane, releasing them into the cytoplasm.
| Target | Nuclear egress protein 1 (gene NEC1; UniProt P0CK47, Epstein-Barr virus) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Epstein-Barr Virus |
| Form | Liquid |
| Formulation | 20 mM PBS; 50% glycerol; 0.02% NaN3 |
| Storage | Store at −20 °C for up to 12 months or 4 °C for up to 1 month. Avoid repeated freeze–thaw cycles. |
Reactivity Notes
The supplier lists reactivity with epstein-barr virus. UniProt places nuclear egress protein 1 in the host nucleus inner membrane.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
